Abbott wins FDA nod for world's smallest rechargeable DBS system
Abbott (NYSE: ABT) announced today that it received approval from the FDA for the launch of its Liberta RC DBS system.
Stay updated with breaking news from Pedro Malha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Abbott (NYSE: ABT) announced today that it received approval from the FDA for the launch of its Liberta RC DBS system.
Abbott (NYSE: ABT) announced today that the FDA approved expanded MRI labeling for its Proclaim DRG neurostimulation system.
With this new approval, people with a Proclaim DRG neurostimulation system can soon receive full-body MRI scans
Abbott received FDA approval for the use of its spinal cord stimulation devices (SCS) for certain people with back pain.
Abbott has announced the FDA expanded the indication of its BurstDR spinal cord stimulation devices for treating chronic back pain in those who have not had or are ineligible for back surgery.